Pakistan to produce HIV prevention injection locally
Pakistan is reportedly considering the local production of a new HIV prevention injection, a move aimed at improving access to life-saving medication and reducing the country’s reliance on imports. Health authorities say producing the injection domestically could make the treatment more affordable and widely available to at-risk populations.
Officials explained that the injection, which has been shown to reduce the risk of HIV infection, is currently in limited supply and costly when imported. By establishing local manufacturing, Pakistan aims to strengthen its public health response, increase availability for vulnerable groups, and ensure timely delivery of the medication across the country.
Health experts note that wider access to preventive HIV injections could play a crucial role in controlling the spread of the virus. The initiative aligns with broader national strategies to enhance HIV awareness, testing, and preventive measures, particularly among high-risk populations such as healthcare workers, sex workers, and individuals in urban centres with high transmission rates.
The proposed local production is expected to involve collaboration between government health agencies and pharmaceutical companies. Authorities are assessing infrastructure, regulatory approvals, and quality control measures to ensure that domestically produced injections meet international safety and efficacy standards.
Public health advocates have welcomed the initiative, emphasizing that local production could lower costs, improve adherence to prevention programs, and reduce the incidence of new HIV infections over time. Observers also note that this move could position Pakistan as a regional hub for affordable HIV prevention solutions in the future.
About the Author
